The issue no one wants to address about blood donation and Black Canadians

For years, a peculiar narrative has circulated: around blood collection African, Caribbean and Black communities in Canada do not donate enough.

That claim deserves scrutiny.

Across the country, blood collection is managed by two institutions: Canadian Blood Services (outside Quebec) and Héma-Québec (in Quebec). Both have repeatedly identified increasing donations from Black communities as a priority, engaging community leaders, hosting advisory conversations and encouraging targeted recruitment.

Yet one central policy remains largely unexamined in public discussion: malaria-related donor deferrals – three months for anyone returning from short-term travel to malaria risk areas; three years for those who have spent six months or more in those areas. And permanently deferred if you’ve ever had malaria. These regions include much of Sub-Saharan Africa and parts of the Caribbean – the very places many African and Caribbean Canadians originate from or travel to visit family.

The result is predictable.

A significant proportion of otherwise healthy potential donors from these communities are ruled ineligible before they ever sit in a donation chair. And yet, public messaging continues to emphasize “low participation” from Black communities.

That framing raises a fundamental question: How can a system characterize a community as underperforming while simultaneously maintaining policies that disproportionately exclude that same community?

Community organizations have spent more than a decade mobilizing donors. Leaders have knocked on doors, hosted blood drives, recruited youth ambassadors, participated in advisory committees and even co-initiated research projects examining barriers to donation.

If the issue were simply awareness or willingness, sustained outreach would have produced dramatic change by now.

Instead, participation rates remain low while deferrals remain high.

This is not a question of safety versus inclusion. Safety must be paramount. The issue is whether Canada’s malaria deferral framework reflects current science and testing capabilities or whether it relies on broad categorical exclusions that are administratively simple but socially inequitable.

Other countries such as the U.S., France and the U.K. have modernized deferral policies over time as screening and risk assessment tools improved. The public deserves clarity on whether Canada’s current criteria are the least restrictive scientifically justified option – or whether they persist largely unchanged.

Why is the burden of solving this framed primarily as a community responsibility?

Another question deserves attention: Why is the burden of solving this framed primarily as a community responsibility?

Black Canadians are disproportionately affected by sickle cell disease, a condition that often requires chronic blood transfusion or red blood cell exchange therapy. Patients and families are repeatedly encouraged to mobilize their networks to donate.

At the same time, many of those very networks are deferred under malaria-related criteria, creating a structural contradiction – communities asked to “step up” while a key eligibility barrier remains intact.

If equity in health systems is a stated priority, then transparency must follow.

• How many potential donors are deferred annually due to malaria-related criteria?
• What proportion of those deferrals affect African and Caribbean Canadians?
• What modelling has been done to assess whether updated testing protocols could safely reduce exclusion?
• What is the timeline for policy reassessment?

These are not emotional questions. They are governance questions.

The integrity of the blood supply depends on public trust. Trust depends on transparency. And transparency requires institutions to explain not only their outreach strategies, but also the structural rules that shape who is allowed to participate.

The issue is not whether Black communities care enough to donate.

The issue is whether Canada’s blood system is structured in a way that makes equitable participation realistically possible.

Until that question is directly addressed, the narrative of “low donation rates” risks misplacing responsibility – and obscuring the policy choices that deserve public examination.